SynFutures vs Mira — how do they compare? SynFutures trades at Rp47.26 (market cap Rp220,97M, Rp44,89M 24h volume), while Mira trades at Rp698.38 (market cap Rp224,01M, Rp102,95M 24h volume). The key difference: SynFutures and Mira are close in size by market cap, and SynFutures's circulating supply is 4,7B / 10B F (47%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold SynFutures for 15 Days and Mira for 22 Days on average.
| F | MIRA | |
|---|---|---|
Market Cap | Rp220,97M | Rp224,01M |
Volume (24h) | Rp44,89M | Rp102,95M |
Circulating Supply | 4,7B / 10B F (47%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 15 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
SynFutures token F is currently trading at Rp48,293 with a market cap of Rp226.58M, showing bearish technical signals with 18 sell indicators versus 2 buy signals. The token faces selling pressure below the pivot point of Rp48, with immediate support at Rp47 and resistance at Rp50. With only 47% of the 10M max supply in circulation and average hold time of 15 days, the token shows moderate network activity.
Overall outlook remains cautious with bearish momentum dominating. Key opportunity lies in potential bounce from support levels, while major risks include low liquidity and continued selling pressure. Investors should monitor for protocol updates and exchange listing developments that could improve market sentiment.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
SynFutures (F) is a decentralized exchange (DEX) and financial infrastructure for the future of trading. With its Oyster AMM and on-chain matching engine, it lets anyone list and trade derivatives with leverage.
Read more on F →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →